Market Closed -
Fukuoka Stock Exchange
10:03:54 15/05/2024 am IST
|
5-day change
|
1st Jan Change
|
1,392
JPY
|
+0.07%
|
|
-3.67%
|
+20.00%
|
Fiscal Period: November |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
985.7
|
943.3
|
958.6
|
1,353
|
1,214
|
1,087
|
Enterprise Value (EV)
1 |
1,286
|
1,494
|
1,305
|
1,208
|
1,386
|
1,768
|
P/E ratio
|
9.42
x
|
7.31
x
|
6.57
x
|
4.32
x
|
5.73
x
|
30.3
x
|
Yield
|
1.95%
|
1.83%
|
1.9%
|
1.77%
|
2.37%
|
2.16%
|
Capitalization / Revenue
|
0.15
x
|
0.14
x
|
0.14
x
|
0.19
x
|
0.17
x
|
0.18
x
|
EV / Revenue
|
0.19
x
|
0.22
x
|
0.19
x
|
0.17
x
|
0.19
x
|
0.29
x
|
EV / EBITDA
|
7.18
x
|
6.47
x
|
4.85
x
|
2.42
x
|
4.13
x
|
16.5
x
|
EV / FCF
|
3.7
x
|
-8.51
x
|
6.48
x
|
2.5
x
|
-5.56
x
|
-3.07
x
|
FCF Yield
|
27.1%
|
-11.7%
|
15.4%
|
39.9%
|
-18%
|
-32.6%
|
Price to Book
|
0.42
x
|
0.38
x
|
0.37
x
|
0.47
x
|
0.39
x
|
0.35
x
|
Nbr of stocks (in thousands)
|
959
|
959
|
959
|
958
|
958
|
941
|
Reference price
2 |
1,028
|
984.0
|
1,000
|
1,412
|
1,267
|
1,155
|
Announcement Date
|
22/02/19
|
21/02/20
|
26/02/21
|
24/02/22
|
27/02/23
|
28/02/24
|
Fiscal Period: November |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
6,692
|
6,729
|
6,711
|
7,032
|
7,242
|
5,998
|
EBITDA
1 |
179
|
231
|
269
|
500
|
336
|
107
|
EBIT
1 |
96
|
136
|
159
|
393
|
233
|
-11
|
Operating Margin
|
1.43%
|
2.02%
|
2.37%
|
5.59%
|
3.22%
|
-0.18%
|
Earnings before Tax (EBT)
1 |
149
|
184
|
206
|
443
|
298
|
53
|
Net income
1 |
105
|
129
|
146
|
313
|
212
|
36
|
Net margin
|
1.57%
|
1.92%
|
2.18%
|
4.45%
|
2.93%
|
0.6%
|
EPS
2 |
109.1
|
134.6
|
152.3
|
326.6
|
221.2
|
38.08
|
Free Cash Flow
1 |
347.9
|
-175.5
|
201.2
|
482.5
|
-249.1
|
-576.5
|
FCF margin
|
5.2%
|
-2.61%
|
3%
|
6.86%
|
-3.44%
|
-9.61%
|
FCF Conversion (EBITDA)
|
194.34%
|
-
|
74.81%
|
96.5%
|
-
|
-
|
FCF Conversion (Net income)
|
331.31%
|
-
|
137.84%
|
154.15%
|
-
|
-
|
Dividend per Share
2 |
20.00
|
18.00
|
19.00
|
25.00
|
30.00
|
25.00
|
Announcement Date
|
22/02/19
|
21/02/20
|
26/02/21
|
24/02/22
|
27/02/23
|
28/02/24
|
Fiscal Period: November |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
300
|
551
|
346
|
-
|
172
|
681
|
Net Cash position
1 |
-
|
-
|
-
|
145
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.676
x
|
2.385
x
|
1.286
x
|
-
|
0.5119
x
|
6.364
x
|
Free Cash Flow
1 |
348
|
-176
|
201
|
483
|
-249
|
-577
|
ROE (net income / shareholders' equity)
|
4.74%
|
5.5%
|
5.79%
|
11.4%
|
7.03%
|
1.34%
|
ROA (Net income/ Total Assets)
|
0.9%
|
1.23%
|
1.4%
|
3.33%
|
1.85%
|
-0.09%
|
Assets
1 |
11,638
|
10,499
|
10,404
|
9,400
|
11,433
|
-40,909
|
Book Value Per Share
2 |
2,477
|
2,604
|
2,708
|
3,008
|
3,222
|
3,292
|
Cash Flow per Share
2 |
1,720
|
1,593
|
1,772
|
2,255
|
2,175
|
1,747
|
Capex
1 |
55
|
147
|
91
|
78
|
249
|
351
|
Capex / Sales
|
0.82%
|
2.18%
|
1.36%
|
1.11%
|
3.44%
|
5.85%
|
Announcement Date
|
22/02/19
|
21/02/20
|
26/02/21
|
24/02/22
|
27/02/23
|
28/02/24
|
|
1st Jan change
|
Capi.
|
---|
| +20.00% | 7.97M | | +1.84% | 3.59B | | -19.91% | 2.16B | | -9.22% | 1.95B | | +4.48% | 1.89B | | +0.55% | 1.71B | | -2.68% | 1.31B | | +4.00% | 1.18B | | -19.72% | 1.07B | | +0.86% | 1.04B |
Pesticide
|